First Allied Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$249K	Buy	2,237 +102	+5%	+$11.4K	0.01%	977
2020 Q2	$239K	Sell	2,135 -451	-17%	-$44.4K	0.01%	927
2020 Q1	$200K	Sell	2,586 -295	-10%	-$26.1K	0.01%	943
2019 Q4	$270K	Sell	2,881 -69	-2%	-$5.97K	0.01%	984
2019 Q3	$221K	Buy	2,950 +302	+11%	+$25.1K	0.01%	1051
2019 Q2	$232K	Sell	2,648 -89	-3%	-$7.59K	0.01%	1026
2019 Q1	$244K	Sell	2,737 -605	-18%	-$51.5K	0.01%	968
2018 Q4	$238K	Sell	3,342 -30,303	-90%	-$2.44M	0.01%	881
2018 Q3	$3.23M	Buy	33,645 +25,379	+307%	+$2.46M	0.11%	211
2018 Q2	$786K	Sell	8,266 -17	-0.2%	-$1.56K	0.03%	526
2018 Q1	$727K	Buy	8,283 +5,979	+260%	+$546K	0.03%	545
2017 Q4	$195K	Buy	+2,304	New	+$193K	0.01%	1068
2017 Q2	–	Sell	-13,866	Closed	-$962K	–	1202
2017 Q1	$962K	Buy	13,866 +7,439	+116%	+$500K	0.05%	388
2016 Q4	$380K	Sell	6,427 -1,237	-16%	-$76.4K	0.02%	689
2016 Q3	$508K	Buy	7,664 +2,940	+62%	+$182K	0.03%	560
2016 Q2	$257K	Buy	4,724 +616	+15%	+$33.8K	0.01%	813
2016 Q1	$212K	Sell	4,108 -204	-5%	-$10.6K	0.01%	881
2015 Q4	$306K	Buy	4,312 +178	+4%	+$12.1K	0.02%	761
2015 Q3	$256K	Sell	4,134 -1,791	-30%	-$141K	0.01%	814
2015 Q2	$496K	Sell	5,925 -174	-3%	-$13.5K	0.02%	617
2015 Q1	$467K	Buy	+6,099	New	+$426K	0.03%	598